Updated on 2025/10/23

写真a

 
Morimoto Daisaku
 
Organization
Scheduled update Special-Appointment Assistant Professor
Position
Special-Appointment Assistant Professor
External link

Degree

  • Ph.D. ( 2021.3   Okayama University )

Research Interests

  • oxidative stress

  • Chronic lung disease

  • Neonatal abstinence syndrome

  • 機械学習

Research Areas

  • Life Science / Embryonic medicine and pediatrics  / Neonatology

Education

  • Okayama University   大学院医歯薬学総合研究科   小児医科学

    2018.4 - 2021.3

      More details

Research History

  • Okayama University   Graduate School of Medicine , Dentistry and Pharmaceutical Sciences   Assistant Professor

    2023.4

      More details

  • Okayama University   Graduate School of Medicine , Dentistry and Pharmaceutical Sciences   clinical fellow

    2018.4 - 2023.3

      More details

Committee Memberships

  • 公益社団法人 日本新生児成育医学会   薬事委員会  

    2024.11 - 2028.11   

      More details

  • 公益社団法人 日本新生児成育医学会   医療安全委員会  

    2024.11 - 2028.11   

      More details

 

Papers

  • Long-term survival of an infant with complete tetraploidy: A case report. Reviewed International journal

    Tomoka Okamura, Junko Yoshimoto, Daisaku Morimoto, Hirokazu Wanatabe, Yosuke Washio

    American journal of medical genetics. Part A   e63717   2024.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We present the case of a girl with complete tetraploidy who has survived to her present age of 4 years and 1 month. Infants with complete tetraploidy have been described to have a limited lifespan owing to complications. We report her characteristics, medical history, and development.

    DOI: 10.1002/ajmg.a.63717

    PubMed

    researchmap

  • Postnatal longitudinal analysis of serum nitric oxide and eosinophil counts in extremely preterm infants Reviewed

    Hirokazu Watanabe, Yosuke Washio, Kei Tamai, Daisaku Morimoto, Tomoka Okamura, Junko Yoshimoto, Hidehiko Nakanishi, Misao Kageyama, Atsushi Uchiyama, Hirokazu Tsukahara, Satoshi Kusuda

    Pediatrics & Neonatology   2024.5

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pedneo.2023.08.006

    researchmap

  • Machine Learning to Improve Accuracy of Transcutaneous Bilirubinometry. Reviewed International journal

    Daisaku Morimoto, Yosuke Washio, Kana Fukuda, Takeshi Sato, Tomoka Okamura, Hirokazu Watanabe, Junko Yoshimoto, Maki Tanioka, Hirokazu Tsukahara

    Neonatology   1 - 8   2024.4

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: This study aimed to develop models for predicting total serum bilirubin by correcting errors of transcutaneous bilirubin using machine learning based on neonatal biomarkers that could affect spectrophotometric measurements of tissue bilirubin. METHODS: This retrospective study included infants born at our hospital (≥36 weeks old, ≥2,000 g) between January 2020 and December 2022. Infants without a phototherapy history were included. Robust linear regression, gradient boosting tree, and neural networks were used for machine learning models. A neural network, inspired by the structure of the human brain, was designed comprising three layers: input, intermediate, and output. RESULTS: Totally, 683 infants were included. The mean (minimum-maximum) gestational age, birth weight, participant age, total serum bilirubin, and transcutaneous bilirubin were 39.0 (36.0-42.0) weeks, 3,004 (2,004-4,484) g, 2.8 (1-6) days of age, 8.50 (2.67-18.12) mg/dL, and 7.8 (1.1-18.1) mg/dL, respectively. The neural network model had a root mean square error of 1.03 mg/dL and a mean absolute error of 0.80 mg/dL in cross-validation data. These values were 0.37 mg/dL and 0.28 mg/dL, smaller compared to transcutaneous bilirubin, respectively. The 95% limit of agreement between the neural network estimation and total serum bilirubin was -2.01 to 2.01 mg/dL. Unnecessary blood draws could be reduced by up to 78%. CONCLUSION: Using machine learning with transcutaneous bilirubin, total serum bilirubin estimation error was reduced by 25%. This integration could increase accuracy, lessen infant discomfort, and simplify procedures, offering a smart alternative to blood draws by accurately estimating phototherapy thresholds.

    DOI: 10.1159/000535970

    PubMed

    researchmap

  • Longitudinal Measurement of Histidine-Rich Glycoprotein Levels in Bronchopulmonary Dysplasia: A Pilot Study Reviewed International journal

    Daisaku Morimoto, Yosuke Washio, Kei Tamai, Takeshi Sato, Tomoka Okamura, Hirokazu Watanabe, Yu Fukushima, Junko Yoshimoto, Misao Kageyama, Kenji Baba, Hirokazu Tsukahara

    Biomedicines   11 ( 1 )   2023.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Histidine-rich glycoprotein (HRG) has been reported to inhibit signaling leading to the release of high mobility group box 1 protein, a damage-associated molecular pattern. The present study aimed to determine the longitudinal change in HRG levels in extremely preterm infants and assess whether complications such as bronchopulmonary dysplasia (BPD) were associated with differences in HRG levels. In this multicenter, prospective, observational study, we measured serum HRG levels every 2 weeks from birth to 8 weeks of age. Serum HRG was measured using an enzyme-linked immunosorbent assay. We included 19 extremely preterm infants in the study and 74 samples were analyzed. The median gestational age was 26.0 weeks, and the median birth weight was 858 g. Serum HRG levels showed a significant upward trend after birth (p < 0.001); median HRG concentrations at birth and at 2, 4, 6, and 8 weeks of age were 1.07, 1.11, 2.86, 6.05, and 7.49 µg/mL, respectively. Onset of BPD was not associated with differences in serum HRG levels. Further, the serum HRG levels increased significantly after birth in extremely preterm infants.

    DOI: 10.3390/biomedicines11010212

    PubMed

    researchmap

  • Prediction model for nonopiate-induced neonatal abstinence syndrome. Reviewed International journal

    Daisaku Morimoto, Yosuke Washio, Takeshi Sato, Tomoka Okamura, Hirokazu Watanabe, Junko Yoshimoto, Hirokazu Tsukahara

    Pediatrics international : official journal of the Japan Pediatric Society   65 ( 1 )   e15435   2022.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Neonatal abstinence syndrome (NAS) induced by opiate use is common worldwide. While psychiatric drugs are a more common cause of NAS in Japan, infants of mothers taking psychiatric medications do not always develop NAS. The purpose of this study was to develop a practical model for predicting the onset of nonopiate-induced NAS using variables available at birth. METHODS: In this diagnostic study, prediction models were developed using multivariable logistic regression with retrospective data collected at our hospital between 2010 and 2019. NAS diagnosis was based on the Isobe score, and maternal medications were converted to dose equivalents. RESULTS: A total of 164 maternal and infant dyads met the inclusion criteria; 91 were included in the analysis, of whom 29 infants (32%) were diagnosed with NAS. Final models were created with and without the drug indices. The model without the drug indices consisted of neonatal head circumference in z-score and Apgar score at 5 minutes < 9, and the model with the drug indices included these, as well as antipsychotics and hypnotics indices. The C-statistics were 0.747 (95% CI: 0.638-0.856), and 0.795 (95% CI: 0.683-0.907), respectively, indicating good predictive accuracy of NAS onset for the models. CONCLUSIONS: This study developed models that predicted nonopiate-induced NAS with good accuracy, which may be further improved through the use of drug indices.

    DOI: 10.1111/ped.15435

    PubMed

    researchmap

  • Head circumference in infants with nonopiate-induced neonatal abstinence syndrome. Reviewed International journal

    Daisaku Morimoto, Yosuke Washio, Kazuki Hatayama, Tomoka Okamura, Hirokazu Watanabe, Junko Yoshimoto, Hirokazu Tsukahara

    CNS spectrums   26 ( 5 )   509 - 512   2021.10

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Cambridge University Press ({CUP})  

    BACKGROUND: No relationship has been reported between nonopiate neonatal abstinence syndrome (NAS) and anthropometric indices, including head circumference (HC). The purpose of this study was to determine the relationship between maternal nonopioid drug use and HC at birth in neonates with NAS. METHODS: This retrospective observational study included neonates born between January 1, 2010 and March 31, 2019, whose mothers had been taking antipsychotic, antidepressant, sedative, or anticonvulsant medications. The outcome measures were HCs of NAS infants and controls. RESULTS: Of 159 infants, 33 (21%) were diagnosed with NAS. There was no maternal opioid use among mothers during pregnancy. The HCs in the NAS group were significantly smaller than those in the control group. The median z-scores for HC at birth were -0.20 and 0.29 in the NAS group and the control group, respectively (P = .011). The median HCs at birth were 33.0 and 33.5 cm in the NAS group and the control group, respectively. Multivariate analysis revealed that maternal antipsychotic drug use and selective serotonin reuptake inhibitors were independently associated with NAS (P < .001 and P = .004, respectively). Notably, benzodiazepine use and smoking were not independent risk factors. CONCLUSIONS: The results suggest an association between maternal antipsychotic drug use and NAS, which was further associated with decreased HC. Careful monitoring of maternal drug use should be considered to improve fetal outcomes.

    DOI: 10.1017/S1092852920001522

    PubMed

    researchmap

▼display all

MISC

▼display all

Research Projects

  • 早産児晩期循環不全の新しい予防・治療戦略に向けた病態解明と予測マーカーの開発

    Grant number:25K11057  2025.04 - 2029.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    鷲尾 洋介, 妹尾 朋香, 津下 充, 玉井 圭, 森本 大作

      More details

    Grant amount:\2860000 ( Direct expense: \2200000 、 Indirect expense:\660000 )

    researchmap

 

Class subject in charge

  • Perinatal and Neonatal Medicine (2025academic year) special  - その他

  • Perinatal and Neonatal Medicine (2024academic year) special  - その他

  • Elective Clinical Practice (Pediatrics) (2024academic year) special  - その他